These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 19256030)
1. Genetically elevated C-reactive protein and vascular disease. Bubb MR N Engl J Med; 2009 Feb; 360(9):933-4; author reply 934-5. PubMed ID: 19256030 [No Abstract] [Full Text] [Related]
2. Genetically elevated C-reactive protein and vascular disease. Morita H; Nagai R N Engl J Med; 2009 Feb; 360(9):934; author reply 934-5. PubMed ID: 19256031 [No Abstract] [Full Text] [Related]
3. [C-reactive protein and risk of ischaemic vascular and cerebrovascular disease--secondary publication]. Zacho J; Tybjaerg-Hansen A; Jensen JS; Grande P; Sillesen H; Nordestgaard BG Ugeskr Laeger; 2009 May; 171(21):1751-5. PubMed ID: 19492468 [TBL] [Abstract][Full Text] [Related]
4. Elevated C-reactive protein in atherosclerosis--chicken or egg? Schunkert H; Samani NJ N Engl J Med; 2008 Oct; 359(18):1953-5. PubMed ID: 18971498 [No Abstract] [Full Text] [Related]
5. Genetically elevated C-reactive protein and vascular disease. Harbord RM; Lawlor DA; Smith GD N Engl J Med; 2009 Feb; 360(9):933; author reply 934-5. PubMed ID: 19246369 [No Abstract] [Full Text] [Related]
6. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander? Nordestgaard BG; Zacho J Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857 [TBL] [Abstract][Full Text] [Related]
7. Genetically elevated C-reactive protein and ischemic vascular disease. Zacho J; Tybjaerg-Hansen A; Jensen JS; Grande P; Sillesen H; Nordestgaard BG N Engl J Med; 2008 Oct; 359(18):1897-908. PubMed ID: 18971492 [TBL] [Abstract][Full Text] [Related]
8. [Possible association between serum C-reactive protein concentrations and ischemic heart disease]. Shapira I; Zeltzer D; Berliner S Harefuah; 1999 Aug; 137(3-4):149-53. PubMed ID: 10959309 [No Abstract] [Full Text] [Related]
11. Gene-environment interaction in the determination of levels of plasma fibrinogen. Humphries SE; Luong LA; Montgomery HE; Day IN; Mohamed-Ali V; Yudkin JS Thromb Haemost; 1999 Aug; 82(2):818-25. PubMed ID: 10605788 [No Abstract] [Full Text] [Related]
12. Commentary: Social class, C-reactive protein and coronary heart disease. Casas JP Int J Epidemiol; 2008 Apr; 37(2):299-300. PubMed ID: 18285367 [No Abstract] [Full Text] [Related]
13. Clinical applications of DNase I, a genetic marker already used for forensic identification. Yasuda T; Kawai Y; Ueki M; Kishi K Leg Med (Tokyo); 2005 Jul; 7(4):274-7. PubMed ID: 15946886 [TBL] [Abstract][Full Text] [Related]
14. Commentary: genes as instruments for evaluation of markers and causes. Glynn RJ Int J Epidemiol; 2006 Aug; 35(4):932-4. PubMed ID: 16854935 [No Abstract] [Full Text] [Related]
19. Genetics of C-reactive protein: new possibilities and complications. Kluft C; de Maat MP Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):1956-9. PubMed ID: 14617617 [No Abstract] [Full Text] [Related]
20. Association of the -757T>C polymorphism in the CRP gene with circulating C-reactive protein levels and carotid atherosclerosis. Ben Assayag E; Shenhar-Tsarfaty S; Bova I; Berliner S; Usher S; Peretz H; Shapira I; Bornstein NM Thromb Res; 2009 Sep; 124(4):458-62. PubMed ID: 19428053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]